Mediclinic International plc Director/PDMR Shareholding (3188Y)
05 December 2017 - 1:30AM
UK Regulatory
TIDMMDC
RNS Number : 3188Y
Mediclinic International plc
04 December 2017
Mediclinic International PLC
(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
LEI: 2138002S5BSBIZTD5I60
("Mediclinic" or the "Company")
4 December 2017
Purchase of shares in Mediclinic by Dr Carel Aron van der
Merwe
On 1 December 2017, Dr Carel Aron van der Merwe acquired 10,000
shares in the Company at a weighted average share price of ZAR
102.69 per share. Accordingly, Dr Van der Merwe now owns a total of
40,630 shares in Mediclinic International plc.
The following notification is made in accordance with Articles
19.1 and 19.3 of the Market Abuse Regulation.
NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL
RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
1. Details of PDMR / person closely associated
with them ("PCA")
--- -----------------------------------------------------
a) Name Dr Carel Aron van der Merwe
--- --------------------- ------------------------------
2. Reason for the notification
--- -----------------------------------------------------
a) Position Chief Clinical Officer of the
/ status Company
--- --------------------- ------------------------------
b) Initial notification Initial Notification
/ amendment
--- --------------------- ------------------------------
3. Details of the issuer, emission allowance
market participant, auction platform, auctioneer
or auction monitor
--- -----------------------------------------------------
a) Name Mediclinic International plc
--- --------------------- ------------------------------
b) LEI 2138002S5BSBIZTD5I60
--- --------------------- ------------------------------
4. Details of the transaction(s): section to
be repeated for (i) each type of instrument;
(ii) each type of transaction; (iii) each
date; and (iv) each place where transactions
have been conducted
--- -----------------------------------------------------
a) Description Ordinary Shares
of the financial
instrument
GB00B8HX8Z88
Identification
Code
--- --------------------- ------------------------------
b) Nature of Purchase of shares
the transaction
--- --------------------- ------------------------------
c) Price(s) Prices (ZAR) Volumes
and volume(s) ------------- --------
102.64 1,000
------------- --------
102.65 474
------------- --------
102.67 690
------------- --------
102.68 1,612
------------- --------
102.69 2,224
------------- --------
102.71 4,000
------------- --------
--- --------------------- ------------------------------
d) Aggregated
information
Aggregated 10,000
volume
ZAR 102.69 per share
Price
--- --------------------- ------------------------------
e) Date of the 1 December 2017; 11:18 UTC
transaction
--- --------------------- ------------------------------
f) Place of Johannesburg Stock Exchange
the transaction
--- --------------------- ------------------------------
About Mediclinic International plc
Mediclinic is an international private healthcare group with
operating platforms in Southern Africa (South Africa and Namibia),
Switzerland and the United Arab Emirates. Its core purpose is to
enhance the quality of life of patients by providing acute care,
specialist-orientated, multi-disciplinary healthcare services.
Mediclinic also holds a 29.9% interest in Spire Healthcare Group
plc, a LSE listed and UK-based private healthcare group.
Mediclinic comprises 75 hospitals and 29 clinics. Mediclinic
Southern Africa operates 49 hospitals and 2 day clinics throughout
South Africa and 3 hospitals in Namibia with more than 8 000
inpatient beds in total; Hirslanden operates 17 private acute care
facilities and 4 clinics in Switzerland with more than 1 700
inpatient beds; and Mediclinic Middle East operates 6 hospitals and
23 clinics with more than 700 inpatient beds in the United Arab
Emirates.
During February 2016, the combination of the Company (previously
named Al Noor Hospitals Group plc), with operations mainly in Abu
Dhabi in the United Arab Emirates, and Mediclinic International
Limited was completed. Mediclinic International Limited was a South
African based international private healthcare group founded in
1983 and listed on the JSE, the South African stock exchange, since
1986, with operations in South Africa, Namibia, Switzerland and the
United Arab Emirates (mainly in Dubai). The combination resulted in
the renaming of the enlarged group to Mediclinic International
plc.
Mediclinic has a primary listing on the Main Market of the LSE,
with secondary listings on the JSE in South Africa and the NSX in
Namibia.
For further information, please contact:
Company Secretary, Link Company Matters Limited
Victoria Dalby / Caroline Emmet
+44 (0)20 7954 9600
Investor Relations, Mediclinic International plc
James Arnold, Head of Investor Relations
ir@mediclinic.com
+44 (0)20 3786 8181
Media queries
FTI Consulting
Brett Pollard / Debbie Scott (UK)
+44 (0)20 3727 1000
Frank Ford (South Africa)
+27 (0)21 487 9000
Registered address: 6th Floor, 65 Gresham Street, London, EC2V
7NQ, United Kingdom
Website: www.mediclinic.com
Corporate broker: Morgan Stanley & Co International plc
JSE sponsor: RAND MERCHANT BANK (A division of FirstRand Bank
Limited)
NSX sponsor: Simonis Storm Securities (Pty) Ltd
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHBSBDDGBGBGRS
(END) Dow Jones Newswires
December 04, 2017 09:30 ET (14:30 GMT)
Mediclinic (LSE:MDC)
Historical Stock Chart
From Apr 2024 to May 2024
Mediclinic (LSE:MDC)
Historical Stock Chart
From May 2023 to May 2024